Tenax Therapeutics
TENX
19 hedge funds and large institutions have $20.3M invested in Tenax Therapeutics in 2016 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 5 closing their positions.
6,082% more call options, than puts
Call options by funds: $2.41M | Put options by funds: $39K
0% more ownership
Funds ownership: 0% → 0% (+0%)
17% less funds holding
Funds holding: 23 → 19 (-4)
27% less capital invested
Capital invested by funds: $27.9M → $20.3M (-$7.57M)
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$939K |
| 2 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
+$704K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$2.47M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.64M |
| 3 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$905K |
| 4 |
CA
Commerzbank Aktiengesellschaft
Frankfurt,
Germany
|
-$176K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$66K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Morgan Stanley
New York
| $10K | – | – | – |
|
|
BIM
27
BlackRock Investment Management
Wilmington,
Delaware
| $8K | – | – | – |
|
|
BA
28
BlackRock Advisors
Wilmington,
Delaware
| $4K | – | – | – |
|
|
AG
29
Advisor Group
Phoenix,
Arizona
| $3K | – | – | – |
|
|
BJ
30
BlackRock Japan
Tokyo,
Japan
| $2K | – | – | – |
|
31
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | – | – | – |
|
|
AC
32
Armistice Capital
New York
| – | -$2.47M | -33 | Closed |
|
|
OM
33
Opaleye Management
Boston,
Massachusetts
| – | -$905K | -12 | Closed |
|
|
BIT
34
BlackRock Institutional Trust
San Francisco,
California
| – | -$66K | -1 | Closed |
|
|
CS
35
Credit Suisse
Zurich,
Switzerland
| – | -$51K | -1 | Closed |
|
36
Renaissance Technologies
New York
| – | -$58K | -1 | Closed |
|
|
IWMPD
37
Integrated Wealth Management (Palm Desert)
Palm Desert,
California
| – | -$1K | – | – |
|
|
SIM
38
Spark Investment Management
New York
| – | -$30K | – | – |
|
TENX Hedge Fund Activity: Q4 2016 in Review
19 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q4 2016, worth a combined $20.3M — down 27% from $27.9M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of TENX and 1 opened new positions — a net loss of 4 holders — while 4 trimmed existing stakes and 1 added.
The largest buyer was Point72 Asset Management, opening a new position worth an estimated $939K. The largest seller was Armistice Capital, exiting entirely with an estimated $2.47M sold.
- 19 institutional investors held Tenax Therapeutics (TENX) as of Q4 2016, down from 23 in Q3 2016.
- Funds reported $20.3M of Tenax Therapeutics stock for Q4 2016, down 27% quarter-over-quarter.
- 1 fund opened new Tenax Therapeutics positions in Q4 2016 and 5 closed out, a net change of -4 holders.
- The largest Tenax Therapeutics buyer in Q4 2016 was Point72 Asset Management, an estimated $939K added.
- The largest Tenax Therapeutics seller in Q4 2016 was Armistice Capital, an estimated $2.47M sold.
Based on aggregated 13F filings for Q4 2016.